ABIONYX Pharma SA

ABIONYX Pharma SA

1.66
EUR
+0.00
(-0.24%)
87.97MMarket Cap
Mar 16Next Earn

Total Valuation

EUR

As of June 30, 2026, ABIONYX Pharma SA carries a market capitalization of 87.97M, placing it among publicly traded companies globally. Its enterprise value stands at 62.74M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap87.97M
Enterprise Value62.74M

Important Dates

ABIONYX Pharma SA's next confirmed earnings release is scheduled for March 16, 2027.

Earnings Date3/16/2027

Share Statistics

As of June 30, 2026, ABIONYX Pharma SA has 42.29M shares outstanding.

Shares Outstanding42.29M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio5.58
P/TBV Ratio8.51

Financial Position

As of June 30, 2026, ABIONYX Pharma SA maintains a current ratio of 5.03, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities.

Current Ratio5.03
Quick Ratio4.61
Debt / Equity10.38

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count49.00

Stock Price Statistics

EUR

As of the close on November 17, 2026, ABIONYX Pharma SA's stock has declined approximately 59.73% over the past 52 weeks. The 50-day moving average sits at 1.67, while the 200-day moving average is 2.51.

52-Week Price Change-59.73%
50-Day Moving Average1.67
200-Day Moving Average2.51

Balance Sheet

EUR

As of June 30, 2026, ABIONYX Pharma SA holds 26.87M in cash and equivalents against 1.64M in total debt, resulting in a net debt position of -26.44M. Total book value stands at 15.78M, with working capital of 23.51M providing operational flexibility.

Cash & Cash Equivalents26.87M
Total Debt1.64M
Net Debt-26.44M
Equity (Book Value)15.78M
Book Value Per Share0.37
Working Capital23.51M

Stock Splits

ABIONYX Pharma SA's most recent stock split took place on May 29, 2026 with a 65:66 split ratio.

Last Split Date5/29/2026
Split Ratio65:66